NASDAQ:DSGN

Design Therapeutics Stock Forecast

etoro logo Buy DSGN
*Your capital is at risk
$15.42
+0.140 (+0.92%)
At Close: Jul 09, 2026
AI Analysis AI Analysis of DSGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DSGN to Watchlist?
Some Reasons Why To Add DSGN:
  • +281.7% price growth over the last year
  • +69.5% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 44.44)
PDF

Design Therapeutics, Inc. stock upgraded to Buy Candidate
(Updated on Jul 09, 2026)

Buy or Hold candidate since Jun 15, 2026 Gain 38.42%

The Design Therapeutics, Inc. stock price gained 0.92% on the last trading day (Thursday, 9th Jul 2026), rising from $15.28 to $15.42. During the last trading day the stock fluctuated 5.43% from a day low at $14.93 to a day high of $15.74. The price has risen in 6 of the last 10 days and is up by 11.9% over the past 2 weeks. Volume fell on the last day by -384 thousand shares and in total, 642 thousand shares were bought and sold for approximately $9.91 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $15.90 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Design Therapeutics, Inc. stock with a 90% probability to be traded between $10.35 and $16.07 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

DSGN Signals & Forecast

The Design Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.00 and $12.18. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -1.41%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Design Therapeutics, Inc. stock

Design Therapeutics, Inc. finds support from accumulated volume at $14.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.81 between high and low, or 5.43%. For the last week, the stock has had daily average volatility of 7.62%.

The Design Therapeutics, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $14.90 (-3.39%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 78 and this increases the risk substantially. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (DSGN) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Design Therapeutics, Inc. to open at $15.36, and during the day (based on 14 day Average True Range), to move between $14.93 and $15.91, which gives a possible trading interval of +/-$0.97 (+/-6.51%) up or down from last closing price. If Design Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.62 (1.30%) than the support at $14.66 (4.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Design Therapeutics, Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Design Therapeutics, Inc. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.063 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 10, 2026 - $15.36 ( 0.367%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DSGN Performance

Trading levels for DSGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.17 4.89%
R2 15.86 2.88%
R1 15.67 1.64%
Price 15.42
S1 15.05 -2.37%
S2 14.86 -3.61%
S3 14.55 -5.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.79 2.40%
R2 15.64 1.43%
R1 15.62 1.30%
Price 15.42
S1 14.66 -4.93%
S2 14.24 -7.65%
S3 13.35 -13.42%

FAQ

What is the symbol for Design Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Design Therapeutics, Inc. is DSGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Design Therapeutics, Inc. Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Design Therapeutics, Inc. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Design Therapeutics, Inc. Stock?
Design Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Design Therapeutics, Inc. Stock.

What's the current price of Design Therapeutics, Inc. Stock?
As of the end of day on the Jul 09, 2026, the price of an Design Therapeutics, Inc. (DSGN) share was $15.42.

What is the 52-week high and low for Design Therapeutics, Inc. Stock?
The 52-week high for Design Therapeutics, Inc. Stock is $17.25 and the 52-week low is $3.60.

What is the market capitalization of Design Therapeutics, Inc. Stock?
As of the Jul 09, 2026, the market capitalization of Design Therapeutics, Inc. is 963.087M.

When is the next earnings date for Design Therapeutics, Inc.?
The upcoming earnings date for Design Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT DESIGN THERAPEUTICS, INC.
Design Therapeutics
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysf...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
20.56% Jun 29
NMRK
$15.02
2.13% Jun 24
NESR
$25.07
11.21% Jun 23
IDYA
$28.98
28.64% Jun 12
GIB
$66.69
0.300% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE